Lobbying organisation

Amgen Canada Inc.

37 meetings with public office holders, Jul 5, 2025 to Jul 26, 2026.

196 meetings on record since the registry opened in 2008.

Meetings over time

  • Jul 2025: 3 meetings, with Sarah Viehbeck, Jocelyne Voisin, Tom Kmiec, Rechie Valdez
  • Aug 2025: 0 meetings
  • Sep 2025: 0 meetings
  • Oct 2025: 7 meetings, with Sandenga Yeba, Justine Frame, Yash Nanda, Karina Gould, Jade Mallette
  • Nov 2025: 2 meetings, with Paul Moen, Tom Kmiec
  • Dec 2025: 6 meetings, with Karim Bardeesy, Chase Knight, Lisa Xie, Sandenga Yeba, Justine Frame
  • Jan 2026: 1 meeting, with Ritu Banerjee
  • Feb 2026: 3 meetings, with Martin Moen, Justine Frame, Dominic LeBlanc, Karim Bardeesy, Janice Charette
  • Mar 2026: 6 meetings, with Jocelyne Voisin, Ian Cameron, Manuela Tomic, Ritu Banerjee, Justine Frame
  • Apr 2026: 1 meeting, with Ali Ehsassi, Elizabeth Wong, Maggie Chi, Justine Frame, Mackenzy Metcalfe
  • May 2026: 2 meetings, with Paul Moen, Karim Bardeesy, Zoe Royer
  • Jun 2026: 3 meetings, with Ritu Banerjee, Paul Moen, Ali Ehsassi
  • Jul 2026: 3 meetings, with Justine Frame, Manuela Tomic, Nasser Haidar
Jul 2025peak 7 in a monthJul 2026

Hover or focus a month to see who was met.

What they lobby about

The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.

Who they met

Liberal8 met · 12 meetings
Conservative1 met · 2 meetings
Not in Arena's member list24 met · 50 meetings
  • Justine Frame
  • Manuela Tomic
  • Ritu Banerjee
  • Paul Moen
  • Sandenga Yeba
  • Elizabeth Wong
  • Jocelyne Voisin
  • Mackenzy Metcalfe
  • Martin Moen
  • Nasser Haidar
  • Annahat Kochhar
  • Chase Knight
  • Greg Orencsak
  • Hosai Zurmati Halim
  • Ian Cameron
  • Jade Mallette
  • Janice Charette
  • Lisa Xie
  • Nasser Haidar
  • Pamela Aung-Thin
  • Sarah Lawley
  • Sarah Viehbeck
  • Shalene Curtis-Micallef
  • Yash Nanda

Health Canada (HC) (21) · Innovation, Science and Economic Development Canada (ISED) (18) · House of Commons (8) · Privy Council Office (PCO) (5) · Treasury Board Of Canada Secretariat (TBS) (4) · Global Affairs Canada (GAC) (2)

In their own words

  • Communicating with government officials about the Food and Drugs Act, including about (i) the approval framework for drug products, such as subsequent entry biologics (also known as biosimilars), (ii) export and cross-border trade restrictions for drug products, (iii) data exclusivity for drug products, (iv) approvals (and subsequent reviews) for new drug submissions, and (v) post-market surveillance of drug products.
  • Communicating with government officials about improved health outcomes, including, but not limited to (i) expanding equitable access to innovative therapies, diagnostics and vaccines, (ii) promoting pricing reform, (iii) enhancing health security, including via the Health Emergency Readiness Canada ("HERC") Agency and (iv) promoting regulatory efficiency, including through regulatory modernization.
  • Communicating with government officials about international trade agreements, including the Canada-United States-Mexico Agreement (CUSMA), formerly known as the North American Free Trade Agreement (NAFTA), more specifically as it relates to trade in the life sciences and biopharmaceutical sectors.

Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.